Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Yersinia pestis bv. Antiqua Threonine--tRNA ligase (thrS) CSB-YP434944YAM
CSB-EP434944YAM
CSB-BP434944YAM
CSB-MP434944YAM
CSB-EP434944YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP434945YAM
CSB-EP434945YAM
CSB-BP434945YAM
CSB-MP434945YAM
CSB-EP434945YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Autoinducer 2-degrading protein lsrG (lsrG) CSB-YP434946YAM
CSB-EP434946YAM
CSB-BP434946YAM
CSB-MP434946YAM
CSB-EP434946YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua tRNA (guanine-N (1)-)-methyltransferase CSB-YP434947YAM
CSB-EP434947YAM
CSB-BP434947YAM
CSB-MP434947YAM
CSB-EP434947YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua DNA mismatch repair protein MutS (mutS), partial CSB-YP434948YAM
CSB-EP434948YAM
CSB-BP434948YAM
CSB-MP434948YAM
CSB-EP434948YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP434949YAM
CSB-EP434949YAM
CSB-BP434949YAM
CSB-MP434949YAM
CSB-EP434949YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN) CSB-YP434950YAM
CSB-EP434950YAM
CSB-BP434950YAM
CSB-MP434950YAM
CSB-EP434950YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP434951YAM
CSB-EP434951YAM
CSB-BP434951YAM
CSB-MP434951YAM
CSB-EP434951YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Ribosomal RNA large subunit methyltransferase G (rlmG) CSB-YP434952YAM
CSB-EP434952YAM
CSB-BP434952YAM
CSB-MP434952YAM
CSB-EP434952YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Penicillin-binding protein activator LpoA (lpoA), partial CSB-YP434953YAM
CSB-EP434953YAM
CSB-BP434953YAM
CSB-MP434953YAM
CSB-EP434953YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua 50S ribosomal protein L13 (rplM) CSB-YP434954YAM
CSB-EP434954YAM
CSB-BP434954YAM
CSB-MP434954YAM
CSB-EP434954YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua p-hydroxybenzoic acid efflux pump subunit AaeA (aaeA), partial CSB-YP434955YAM1
CSB-EP434955YAM1
CSB-BP434955YAM1
CSB-MP434955YAM1
CSB-EP434955YAM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Protein TolB (tolB) CSB-YP434956YAM
CSB-EP434956YAM
CSB-BP434956YAM
CSB-MP434956YAM
CSB-EP434956YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua UPF0370 protein YpAngola_A3139 (YpAngola_A3139), partial CSB-YP434957YAM
CSB-EP434957YAM
CSB-BP434957YAM
CSB-MP434957YAM
CSB-EP434957YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Methionine--tRNA ligase (metG), partial CSB-YP434958YAM
CSB-EP434958YAM
CSB-BP434958YAM
CSB-MP434958YAM
CSB-EP434958YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Lysophospholipid transporter lplT (lplT), partial CSB-YP434959YAM
CSB-EP434959YAM
CSB-BP434959YAM
CSB-MP434959YAM
CSB-EP434959YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Phosphoheptose isomerase (gmhA) CSB-YP434960YAM
CSB-EP434960YAM
CSB-BP434960YAM
CSB-MP434960YAM
CSB-EP434960YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Proline--tRNA ligase (proS), partial CSB-YP434961YAM
CSB-EP434961YAM
CSB-BP434961YAM
CSB-MP434961YAM
CSB-EP434961YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua UPF0352 protein YpAngola_A1485 (YpAngola_A1485) CSB-YP434962YAM
CSB-EP434962YAM
CSB-BP434962YAM
CSB-MP434962YAM
CSB-EP434962YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua 50S ribosomal protein L32 (rpmF) CSB-YP434963YAM
CSB-EP434963YAM
CSB-BP434963YAM
CSB-MP434963YAM
CSB-EP434963YAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>